Clinical Trials Browser

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Histiocytosis, Langerhans-Cell, Neuroblastoma, Neurofibromatosis 1, Oligodendroglioma, Ganglioglioma, Neurocytoma, Neurofibroma, Plexiform

NCT02875314 2026-02-12

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

Phase 4 Active not recruiting

250 enrolled

CNS

Medulloblastoma

NCT06627530 2026-02-11

COAction

Phase 4 Active not recruiting

144 enrolled

Genitourinary

Prostatic Neoplasms

NCT02162849 2026-02-09

Reward Sensitivity and Pharmacotherapy for Smoking Cessation

Phase 4 Active not recruiting

204 enrolled

Smoking Cessation, Tobacco Use Cessation

NCT02584933 2026-02-03

Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study

Phase 4 Active not recruiting

233 enrolled

Tumor-Agnostic

Neoplasms

NCT05252585 2026-02-03

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Phase 4 Active not recruiting

4 enrolled

Tuberous Sclerosis, Angiomyolipoma

NCT01742299 2026-02-02

Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator

Phase 4 Active not recruiting

155 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT05161195 2026-02-02

Roll-over Study to Allow Continued Access to Ribociclib

Phase 4 Active not recruiting

134 enrolled

Breast

Breast Neoplasms

NCT04206813 2026-01-27

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

Phase 4 Active not recruiting

352 enrolled

Papillomavirus Infections

NCT05634720 2026-01-26

Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer

Phase 4 Active not recruiting

20 enrolled

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT07015957 2026-01-12

Kupewa: Optimizing Implementation Strategies for Cervical Cancer Prevention

Phase 4 Active not recruiting

7,000 enrolled

Gynecologic

Cervical Cancer Prevention

NCT04296305 2025-12-26

Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain

Phase 4 Active not recruiting

84 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

Clinical Trials

PRISMA

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

CINC424A2X01B Rollover Protocol

A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)

EpiCom

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

ANTELOPE

Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy

NORTH-REG Dwell-Time Study

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1

Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2

Pediatric Long-Term Follow-up and Rollover Study

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

COAction

Reward Sensitivity and Pharmacotherapy for Smoking Cessation

Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator

Roll-over Study to Allow Continued Access to Ribociclib

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer

Kupewa: Optimizing Implementation Strategies for Cervical Cancer Prevention

Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain